Delivery Order SPE2DE21D7020-SPE2D625F5NV1
- Not listed
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $6,118.95 by the Defense Health Agency's Medical Supply Chain on September 16, 2025. This fixed-price contract with economic price adjustment provisions has an ultimate completion date of September 23, 2025 and carries no set-aside designation, indicating open competition in the federal marketplace. The work will be performed at Boston Scientific's...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $5,050.68 by the Defense Health Agency's Medical Supply Chain program. The contract, issued on August 4, 2025, with an ultimate completion date of August 11, 2025, utilizes fixed-price pricing with economic price adjustment terms and carries no set-aside designation. The place of performance is Boston Scientific's facility in Marlborough,...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $11,312.43 by the Defense Health Agency's Medical Supply Chain program. The contract, awarded on August 14, 2025, with an ultimate completion date of August 21, 2025, utilizes fixed-price pricing with economic price adjustment. The delivery order is to be performed at Boston Scientific's facility in Marlborough, MA, and no small business set-aside...
- Boston Scientific Corp, a major global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $32,850 by the Defense Health Agency's Medical Supply Chain under contract 4569047952. This fixed-price delivery order with economic price adjustment terms carries an ultimate completion date of August 18, 2025, and was issued on August 11, 2025. The contract is not set-aside and represents Boston Scientific's continued role as a prime...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $5,093.05 by the Defense Health Agency's Medical Supply Chain division. The contract, awarded on September 5, 2025, with an ultimate completion date of September 12, 2025, employs a fixed-price with economic price adjustment pricing structure and is not designated as a set-aside contract. Performance will take place at Boston Scientific's facility...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $2,475.34 by the Defense Health Agency's Medical Supply Chain on September 12, 2025. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by September 19, 2025, and represents work to be performed at the company's facility in Marlborough, Massachusetts. The contract carries no set-aside designation,...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $1,416.45 by the Defense Health Agency's Medical Supply Chain on July 29, 2025. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 5, 2025, and will be performed at Boston Scientific's facility in Marlborough, MA. The award uses no set-aside designation, allowing Boston Scientific to compete openly...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $75,560 by the Defense Health Agency's Medical Supply Chain on August 20, 2025, with an ultimate completion date of September 10, 2025. This fixed-price contract with economic price adjustment provisions represents a non-competitive award with no small business set-aside. As the place of performance is Boston Scientific's headquarters location in...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $4,505.50 by the Defense Health Agency's Medical Supply Chain on August 5, 2025. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of August 12, 2025 and involves performance at Boston Scientific's facility in Marlborough, MA. The award was made without a set-aside designation, allowing the company...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $8,795.18 by the Defense Health Agency's Medical Supply Chain on June 24, 2025. The contract employs fixed-price pricing with economic price adjustment terms and is scheduled for completion by July 1, 2025. The award is not set-aside and represents Boston Scientific's continued role as a prime contractor supplying advanced medical devices to federal...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F5NV1Delivery Order
Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $5,120.00 by the Defense Health Agency's Medical Supply Chain division. The contract, issued on June 30, 2025, with an ultimate completion date of July 11, 2025, covers NRG EEPROM high flow 98cm medical equipment under a fixed-price contract with economic price adjustment terms. The place of performance is Boston Scientific's facility in Marlborough, MA. This award was made without a set-aside designation, indicating the company competed openly in the federal marketplace for this medical supply requirement. This delivery order represents a continuation of Boston Scientific's extensive portfolio of federal healthcare contracts, through which the company supplies specialized medical devices to the Department of Defense and Defense Health Agency. As a major federal contractor, Boston Scientific maintains several indefinite delivery vehicles with federal healthcare agencies, including a $750,000 blanket purchase agreement with the DHA for radiation treatment devices through March 30, 2030. The company's federal contract awards demonstrate its critical role as a supplier of advanced cardiovascular, interventional, and diagnostic medical equipment to federal healthcare systems, with contract values ranging from nominal amounts to nearly $1 million.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 6/30/25 |